DrugPatentWatch Database Preview

Tolmar Company Profile

« Back to Dashboard

What is the competitive landscape for TOLMAR, and when can generic versions of TOLMAR drugs launch?

TOLMAR has twenty-five approved drugs.

There are ten US patents protecting TOLMAR drugs.

There are sixty-seven patent family members on TOLMAR drugs in twenty-six countries and sixteen supplementary protection certificates in eight countries.

Summary for Tolmar

International Patents:	67
US Patents:	10
Tradenames:	18
Ingredients:	18
NDAs:	25
Patent Litigation for Tolmar:	See patent lawsuits for Tolmar

Drugs and US Patents for Tolmar

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021379-001	Jul 24, 2002		RX	Yes	Yes	6,773,714		Y
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021731-001	Dec 14, 2004		RX	Yes	Yes	8,840,916		Y
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021731-001	Dec 14, 2004		RX	Yes	Yes	8,486,455		Y	Y
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021343-001	Jan 23, 2002		RX	Yes	Yes	6,626,870		Y
Tolmar	ADAPALENE	adapalene	GEL;TOPICAL	200298-001	Jun 14, 2012	AB	RX	No	No
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021379-001	Jul 24, 2002		RX	Yes	Yes	6,565,874		Y
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021379-001	Jul 24, 2002		RX	Yes	Yes	9,283,282		Y	Y

Expired US Patents for Tolmar

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021488-001	Feb 13, 2003	5,599,552
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021379-001	Jul 24, 2002	6,773,714
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021343-001	Jan 23, 2002	9,254,307
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021488-001	Feb 13, 2003	4,938,763
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021379-001	Jul 24, 2002	9,283,282
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021731-001	Dec 14, 2004	8,486,455
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021343-001	Jan 23, 2002	4,938,763

International Patents for Tolmar Drugs

Country	Document Number	Estimated Expiration
Denmark	1322286
New Zealand	525210
Spain	2219079
Japan	6087886
Mexico	PA03002552
Portugal	1586309
Portugal	1322286

Supplementary Protection Certificates for Tolmar Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C0038	France		PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
00028	Netherlands		PRODUCT NAME: LEVETIRACETAM; REGISTRATION NO/DATE: EU/1/00/146/001 - EU/1/00/146/026 20000929
2008 00029	Denmark		PRODUCT NAME: ADAPALEN, BENZOYLPEROXID
C0024	France		PRODUCT NAME: ADAPALENE - PEROXYDE DE BENZOLE; REGISTRATION NO/DATE IN FRANCE: NL 33724 DU 20080123; REGISTRATION NO/DATE AT EEC: 40440 DU 20071218
C/GB05/029	United Kingdom		PRODUCT NAME: MESOTRIONE (2-(4-METHYLSULPHONYL-2-NITROBENZOYL)-1,3CYCLOHEXANEDIONE); REGISTERED: AU 2726 20001016; UK 0309 OF 2005 20050218
C/GB10/012	United Kingdom		PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
00097	Netherlands		PRODUCT NAME: BOSENTAN, DESGEWENST IN DE VORM VAN EEN ZOUT OF EEN HYDRAAT OF IN DE VORM VAN EEN ESTER VAN DE HYDROXYLGROEP VAN DE 2-HYDROXYETHOXY REST MET EEN ZUUR MET DE FORMULE R5-OH, WAARIN R5 EEN C1-7-ALKANOYL, BENZOYL, OF HETEROCYCLYCARBONYL VOORSTELT; NATL. REGISTRATION NO/DATE: U/1/02/220/001 - 005 20020515; FIRST REGISTRATION: CH IKS 58841 01 - 02 20020228

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Tolmar
• Tolmar Therap